Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
FRTX was delisted on the 18th of December, 2023.
78 hedge funds and large institutions have $41.7M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2014 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 19 reducing their positions, and 11 closing their positions.
334% more call options, than puts
Call options by funds: $317K | Put options by funds: $73K
2% more capital invested
Capital invested by funds: $41.1M → $41.7M (+$634K)
9% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 11
1% less funds holding
Funds holding: 79 → 78 (-1)
16% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
+$1.42M |
| 2 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$973K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$464K |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$424K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$268K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
-$1.79M |
| 2 |
LM
Litespeed Management
New York
|
-$1.64M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$617K |
| 4 |
VAM
Visium Asset Management
New York
|
-$590K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$563K |
FRTX Hedge Fund Activity: Q1 2014 in Review
78 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q1 2014, worth a combined $41.7M — up 1.5% from $41.1M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of FRTX and 10 opened new positions — a net loss of 1 holder — while 19 trimmed existing stakes and 16 added.
The largest buyer was D.E. Shaw & Co, adding an estimated $1.42M. The largest seller was Ariel Investments, cutting an estimated $1.79M.
- 78 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q1 2014, down from 79 in Q4 2013.
- Funds reported $41.7M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q1 2014, up 1.5% quarter-over-quarter.
- 10 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q1 2014 and 11 closed out, a net change of -1 holder.
- The largest Fresh Tracks Therapeutics, Inc. Common Stock buyer in Q1 2014 was D.E. Shaw & Co, an estimated $1.42M added.
- The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q1 2014 was Ariel Investments, an estimated $1.79M sold.
Based on aggregated 13F filings for Q1 2014.